Prostate Cancer Screening and Referral Guidelines

Introduction to Prostate Cancer Screening

The American Urological Association recommends that men with a PSA >4.0 ng/mL should be referred to urology, as this threshold carries a 17-32% cancer detection rate 1, 2, 3
Ejaculation within 48 hours of testing can elevate PSA and should be avoided 1

A PSA >4.0 ng/mL warrants urology referral regardless of other factors 1, 2, 3
A PSA of 4.0-10.0 ng/mL carries a 17-32% cancer risk 3
A PSA of 10.0-20.0 ng/mL carries a 43-65% cancer risk and requires urgent referral within days 1, 3
A PSA >20 ng/mL carries an 84-87% cancer risk 3

Men aged 40-49 should be referred if PSA >2.0 ng/mL (Asian-Americans, African-Americans) or >2.5 ng/mL (Whites) 3
Men aged 50-59 should be referred if PSA >3.0 ng/mL (Asian-Americans), >4.0 ng/mL (African-Americans), or >3.5 ng/mL (Whites) 3
Men aged 60-69 should be referred if PSA >4.0 ng/mL (Asian-Americans) or >4.5 ng/mL (African-Americans, Whites) 3
Men aged 70-79 should be referred if PSA >5.0 ng/mL (Asian-Americans), >5.5 ng/mL (African-Americans), or >6.5 ng/mL (Whites) 3

A PSA increase ≥1.0 ng/mL in any 12-month period warrants immediate referral regardless of baseline PSA value 1, 2, 3
A PSA increase of 0.7-0.9 ng/mL in one year requires repeat PSA in 3-6 months and referral if any further increase 1, 2
A PSA increase >1.5 ng/mL within 2 years warrants referral 2, 3
For PSA <4.0 ng/mL, a velocity >0.35 ng/mL per year is suspicious 1, 3
For PSA 4.0-10.0 ng/mL, a velocity >0.75 ng/mL per year is suspicious 1, 3

Any abnormal DRE finding mandates immediate urology referral regardless of PSA level 2, 3
Any nodule, asymmetry, or areas of increased firmness on DRE warrant immediate referral even if PSA <4.0 ng/mL 2, 3
Abnormal DRE with PSA <4.0 ng/mL still carries 10% cancer risk 3

African American men and those with family history should be referred at lower PSA thresholds 2, 3
Men with first-degree relative diagnosed with prostate cancer before age 65 should receive screening information starting at age 45 and be considered for referral at lower thresholds 4, 2, 3
Men with multiple family members diagnosed before age 65 should receive screening information starting at age 40 4

Refer to urology if any of the following are present, regardless of PSA level: DRE suspicious for prostate cancer, hematuria, recurrent urinary tract infections, palpable bladder, neurological disease affecting urinary function, or pain associated with urinary symptoms 5

Men >75 years with <10-15 years life expectancy should not be offered prostate cancer screening 4, 3
Asymptomatic men with <10 years life expectancy based on age and health status should not be screened 4
Severe comorbidities limiting life expectancy make cancer detection less clinically relevant 3
Men >75 years may not benefit from aggressive workup unless very healthy with minimal comorbidity 1, 3

40-44% of initially elevated PSA values normalize on repeat testing without intervention 3
Repeat PSA after 3-6 weeks if initially elevated to confirm elevation 3
Avoid PSA testing within 3-6 weeks of prostate manipulation, urinary tract infection, or ejaculation 3
Confirm patient abstained from ejaculation for 48 hours before testing 1
Use the same laboratory assay for serial measurements, as assays vary by 20-25% 3